ArticleRheumatology and therapy2026

Impact of the Sociodemographic Index on Efficacy/Safety of Tofacitinib in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Phase 2/3/3b/4 Studies.

Grace Wright et al.PubMed ↗Publisher ↗

No numbers read from the abstract.